We celebrate John Galena’s appointment to the CVS board while he stays on our board, and we share why that healthcare alignment matters. We also lay out why we believe Arrive AI is stronger than ever on people, cash, facility, and IP even as the stock price hits new lows. 
• John Galena joining the CVS board while remaining on our board 
• Why healthcare leadership and Fortune 500 validation matter 
• Our internal snapshot on team strength, cash position, facility, and IP 
• The gap between intrinsic value and market cap at a sub-dollar stock price 
• Execution mode, go-to-market momentum, and what “day one” means 
• Autonomous delivery AI as the intersection of robotics, delivery points, and drones 
• Why a unified ecosystem creates outsized synergy 
• Our approach to transparency, syndication, and not forcing a fixed cadence 
• Focus on near-term deployments close to home while moving fast globally 

If you believe in what we're doing and where we're going, stay on board, jump on board, tell your friends, family, coworkers, tell yourself um this is our moment. 

I want you to all help me build this company to twenty dollars a share right now.